Cargando…

A (18)FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer

OBJECTIVE: The present study investigated the prognosis value of preoperative fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with local advanced gastric cancer (LAGC). METHODS: In total, 144 patients [median age 63 (range: 48−80) years old] with LAGC u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jinling, Li, Zhongwu, Chen, Puyun, Yu, Jiangyuan, Wang, Feng, Yang, Zhi, Wang, Xuejuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736658/ https://www.ncbi.nlm.nih.gov/pubmed/31564806 http://dx.doi.org/10.21147/j.issn.1000-9604.2019.04.07

Ejemplares similares

Metabolic activity via (18)F-FDG PET/CT is predictive of microsatellite instability status in colorectal cancer
por: Song, Jinling, et al.
Publicado: (2022)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

The Use of (18)F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma
por: Hlongwa, Khanyisile N., et al.
Publicado: (2022)

Qualitative and Semiquantitative Parameters of (18)F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule
por: Corica, Ferdinando, et al.
Publicado: (2023)

The Relationship Between HER-2 Expression Levels and (18)F-FDG PET/CT Parameters in Gastric Cancer
por: Ertürk, Seyit Ahmet, et al.
Publicado: (2021)

Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation
por: Li, Yimin, et al.
Publicado: (2019)

Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT
por: Yun, Mijin
Publicado: (2014)

The Role of 18F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence
por: Cayvarlı, Hakan, et al.
Publicado: (2014)

The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer
por: Filik, Mustafa, et al.
Publicado: (2015)

Retrospective Analysis of the Predictive Value of (18)F-FDG PET/CT Metabolic Parameters for PD-L1 Expression in Cervical Cancer
por: Ji, Jianfeng, et al.
Publicado: (2023)

Clinical and Prognostic Value of PET/CT Imaging with Combination of (68)Ga-DOTATATE and (18)F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Zhang, Panpan, et al.
Publicado: (2018)

Diagnostic performance of integrated whole-body (18)F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with (18)F-FDG PET or MRI alone
por: Chen, Xuetao, et al.
Publicado: (2023)

Metabolic Characteristics and Diagnostic Contribution of (18)F-FDG PET/CT in Gastric Carcinomas
por: Arslan, Esra, et al.
Publicado: (2020)

Volumetric parameters on (18)F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET
por: Liu, Guobing, et al.
Publicado: (2019)

Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to (18)F-FDG PET/CT
por: Zheng, Dong, et al.
Publicado: (2020)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Impact of (18)F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
por: Vees, Hansjörg, et al.
Publicado: (2012)

The Role of the Metabolic Parameters of (18)F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
por: Wang, Dunhuang, et al.
Publicado: (2021)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

Prognostic Role of 2-[(18)F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative (131)I WBS and Positive 2-[(18)F]-FDG PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
por: Kunikowska, Jolanta, et al.
Publicado: (2014)

Clinical correlation of metabolic parameters on (18)F-FDG PET/CT in idiopathic frozen shoulder
por: Won, Kyoung Sook, et al.
Publicado: (2017)

Prognostic Significance of Metabolic Parameters by (18)F-FDG PET/CT in Thymic Epithelial Tumors
por: Lee, Joohee, et al.
Publicado: (2021)

A Diagnostic Nomogram Based on (18)F-FDG PET/CT for Bone Metastasis of Gastric Cancer
por: Wu, Chunhui, et al.
Publicado: (2021)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

The impact of baseline (18)F-FDG PET-CT on the management and outcome of patients with gastric cancer
por: Foley, Kieran G, et al.
Publicado: (2022)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

Discordant Metabolic Response on (18)F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma
por: Hao, Wanting, et al.
Publicado: (2022)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy
por: Dębiec, Kinga, et al.
Publicado: (2017)

(18)F-FDG PET/CT metabolic parameters correlate with EIF2S2 expression status in colorectal cancer
por: Yang, Jian-Wei, et al.
Publicado: (2021)

(18)F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
por: Dondi, Francesco, et al.
Publicado: (2021)

Volume-based metabolic parameter of breast cancer on preoperative (18)F-FDG PET/CT could predict axillary lymph node metastasis
por: An, Young-Sil, et al.
Publicado: (2017)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lrp5vl1or8qh77piigj84jd730